GlassScriptPhysician profile
Lakhvir Pabla
NPI 1265054845
$1,396.31
in general payments reported to CMS, 2019-2025
11 companies · $690 in 2025
The $690 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $706 · 2025: $690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $771 · Travel and Lodging: $322 · Education: $280 · Consulting Fee: $23.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $771.26 |
| Travel and Lodging | $321.90 |
| Education | $279.99 |
| Consulting Fee | $23.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $484.90 | 2025 | |
| Medical Device Business Services, INC. | $279.99 | 2024 | |
| Inari Medical, INC. | $162.88 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Urgo Medical North America, LLC | $148.24 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Averitas Pharma INC. | $116.07 | 2024-2025 | Qutenza |
| Kerecis Limited | $52.38 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Stryker Corporation | $45.65 | 2025 | Prostep Mica, Ortholoc 2 Lapifuse, Prostep |
| Zimmer Biomet Holdings, INC. | $34.13 | 2024 | Phoenix, Stratum Foot Plating System, A.L.P.S. |
| Smith+Nephew, INC. | $28.91 | 2025 | Healicoil |
| Next Science LLC | $23.16 | 2024 | Xperience, Surgx, Blastx |
| Organogenesis INC. | $20.00 | 2025 | Affinity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lakhvir Pabla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.